SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Joaquín Fernández-Irigoyen, María Victoria Zelaya, Estela Perez-Valderrama, Enrique Santamaría, New insights into the human brain proteome: Protein expression profiling of deep brain stimulation target areas, Journal of Proteomics, 2015, 127, 395

    CrossRef

  2. 2
    Livia Dézsi, László Vécsei, Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 3, 409

    CrossRef

  3. 3
    Sevgi Sayın, Raif Çakmur, Görsev G. Yener, Erdem Yaka, Burcu Uğurel, Fatma Uzunel, Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson’s disease, Journal of Clinical Neuroscience, 2014, 21, 8, 1373

    CrossRef

  4. 4
    Alfonso Fasano, Francesco Bove, Maurizio Gabrielli, Martina Petracca, Maria Assunta Zocco, Enzo Ragazzoni, Federico Barbaro, Carla Piano, Serena Fortuna, Annalisa Tortora, Raffaella Giacopo, Mariachiara Campanale, Giovanni Gigante, Ernesto Cristiano Lauritano, Pierluigi Navarra, Stefano Marconi, Antonio Gasbarrini, Anna Rita Bentivoglio, The role of small intestinal bacterial overgrowth in Parkinson's disease, Movement Disorders, 2013, 28, 9
  5. 5
    Galit Kleiner-Fisman, Rebecca Martine, Anthony E. Lang, Matthew B. Stern, Development of a Non-Motor Fluctuation Assessment Instrument for Parkinson Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  6. 6
    Ivan Sosa, Ines Strenja Linic, Anja Petaros, Andrej Desnica, Alan Bosnar, The potential value of early screening for neurological deficits in participants in certain sports, Medical Hypotheses, 2011, 77, 4, 633

    CrossRef

  7. 7
    K.A. Stockwell, D.K.A. Scheller, L.A. Smith, S. Rose, M.M. Iravani, M.J. Jackson, P. Jenner, Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or l-DOPA in MPTP-treated common marmosets, Experimental Neurology, 2010, 221, 1, 79

    CrossRef

  8. 8
    Jaime Kulisevsky, Javier Pagonabarraga, Mercè Martinez-Corral, Changes in artistic style and behaviour in Parkinson’s disease: dopamine and creativity, Journal of Neurology, 2009, 256, 5, 816

    CrossRef

  9. You have free access to this content9
    Peter A. LeWitt, M. Guttman, James W. Tetrud, Paul J. Tuite, Akihisa Mori, Philip Chaikin, Neil M. Sussman, Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005), Annals of Neurology, 2008, 63, 3
  10. 10
    Alexander M. Goberman, Michael Blomgren, Fundamental Frequency Change During Offset and Onset of Voicing in Individuals with Parkinson Disease, Journal of Voice, 2008, 22, 2, 178

    CrossRef

  11. 11
    Przemyslaw Nowak, Aleksandra Bortel, Joanna Dabrowska, Izabela Biedka, Grzegorz Slomian, Wojciech Roczniak, Richard M. Kostrzewa, Ryszard Brus, Histamine H3 receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa-derived extracellular dopamine in dopamine-denervated rat striatum, Neurotoxicity Research, 2008, 13, 3-4, 231

    CrossRef

  12. 12
    M. Giorgi, V. D’Angelo, Z. Esposito, V. Nuccetelli, R. Sorge, A. Martorana, A. Stefani, G. Bernardi, G. Sancesario, Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms, European Journal of Neuroscience, 2008, 28, 5
  13. 13
    Xiomara A. Perez, Neeraja Parameswaran, Luping Z. Huang, Kathryn T. O’Leary, Maryka Quik, Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates, Journal of Neurochemistry, 2008, 105, 5
  14. 14
    Javier Pagonabarraga, Carmen García-Sánchez, Gisela Llebaria, Berta Pascual-Sedano, Alexandre Gironell, Jaime Kulisevsky, Controlled study of decision-making and cognitive impairment in Parkinson's disease, Movement Disorders, 2007, 22, 10
  15. 15
    Kenichi Kashihara, Management of levodopa-induced dyskinesias in Parkinson's disease, Journal of Neurology, 2007, 254, S5, 27

    CrossRef

  16. 16
    Dag Nyholm, Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson’s disease, Expert Review of Neurotherapeutics, 2006, 6, 10, 1403

    CrossRef

  17. 17
    Horst Baas, Pharmakotherapie und Leitlinien: Das Parkinson-Syndrom, Pharmazie in unserer Zeit, 2006, 35, 3
  18. 18
    Julie Leegwater-Kim, Cheryl Waters, Tolcapone in the management of Parkinson’s disease, Expert Opinion on Pharmacotherapy, 2006, 7, 16, 2263

    CrossRef